Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area

References

• Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–492. doi:10.1128/CMR.00070-0920610819
   PubMed Web of Science ®Google Scholar
• Gonzalez-Granado LI. Acute bacterial meningitis. Lancet Infect Dis. 2010;10(9):596. doi:10.1016/S1473-3099(10)70184-5
   Web of Science ®Google Scholar
• Jiang H, Su M, Kui L, et al. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012–2015. PLoS One. 2017;12(6):e0180161. doi:10.1371/journal.pone.018016128662145
   PubMed Web of Science ®Google Scholar
• Pellegrini L, Bonfio C, Chadwick J, et al. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;369(6500):eaaz5626. doi:10.1126/science.aaz562632527923
   PubMed Web of Science ®Google Scholar
• Jarousha AM, Afifi AA. Epidemiology and risk factors associated with developing bacterial meningitis among children in gaza strip. Iran J Public Health. 2014;43(9):1176–1183.26175971
   PubMed Web of Science ®Google Scholar
• Shrestha RG, Tandukar S, Ansari S, et al. Bacterial meningitis in children under 15 years of age in Nepal. BMC Pediatr. 2015;15(1):94. doi:10.1186/s12887-015-0416-626286573
   PubMed Web of Science ®Google Scholar
• McCormick DW, Wilson ML, Mankhambo L, et al. Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997–2010. Pediatr Infect Dis J. 2013;32(2):e54–61. doi:10.1097/INF.0b013e31826faf5a22914560
   PubMed Web of Science ®Google Scholar
• Namani S, Milenković Z, Kuchar E, et al. Mortality from bacterial meningitis in children in Kosovo. J Child Neurol. 2012;27(1):46–50.21765151
   PubMed Web of Science ®Google Scholar
• Nickerson JW, A Attaran, BD Westerberg, et al. Fatal bacterial meningitis possibly associated with substandard ceftriaxone–Uganda, 2013. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1375–1377.26720749
   PubMed Web of Science ®Google Scholar
• Chang JB, Wu H, Wang H, et al. Prevalence and antibiotic resistance of bacteria isolated from the cerebrospinal fluid of neurosurgical patients at Peking Union Medical College Hospital. Antimicrob Resist Infect Control. 2018;7(1):41. doi:10.1186/s13756-018-0323-329568514
   PubMed Web of Science ®Google Scholar
• Bartlett AW, Smith B, George CRR, et al. Epidemiology of late and very late onset group b streptococcal disease: fifteen-year experience from two Australian tertiary pediatric facilities. Pediatr Infect Dis J. 2017;36(1):20–24. doi:10.1097/INF.000000000000134527749655
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Guidotti I, et al. Factors associated with intrapartum transmission of group B Streptococcus. Pediatr Infect Dis J. 2014;33(12):1211–1215. doi:10.1097/INF.000000000000043925037035
   PubMed Web of Science ®Google Scholar
• Al Luhidan L, Madani A, Albanyan EA, et al. Neonatal group B streptococcal infection in a tertiary care hospital in Saudi Arabia: a 13-year experience. Pediatr Infect Dis J. 2019;38(7):731–734. doi:10.1097/INF.000000000000226931192978
   PubMed Web of Science ®Google Scholar
• Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations. Prescrire Int. 2011;20(114):72–77.21648230
   PubMedGoogle Scholar
• Romain AS, Cohen R, Plainvert C, et al. Clinical and laboratory features of group b streptococcus meningitis in infants and newborns: study of 848 cases in France, 2001–2014. Clin Infect Dis. 2018;66(6):857–864. doi:10.1093/cid/cix89629045606
   PubMed Web of Science ®Google Scholar
• Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(Rr–10):1–36.
   PubMedGoogle Scholar
• Cagno CK, Pettit JM, Weiss BD. Prevention of perinatal group B streptococcal disease: updated CDC guideline. Am Fam Physician. 2012;86(1):59–65.22962913
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015;28(7):766–782. doi:10.3109/14767058.2014.93480425162923
   PubMed Web of Science ®Google Scholar
• Furyk JS, Swann O, Molyneux E. Systematic review: neonatal meningitis in the developing world. Trop Med Int Health. 2011;16(6):672–679. doi:10.1111/j.1365-3156.2011.02750.x21395927
   PubMed Web of Science ®Google Scholar
• Gervaix A, Taguebue J, Bescher BN, et al. Bacterial meningitis and pneumococcal serotype distribution in children in cameroon. Pediatr Infect Dis J. 2012;31(10):1084–1087. doi:10.1097/INF.0b013e318260552d22653488
   PubMed Web of Science ®Google Scholar
• Alanio A. Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence. J Clin Invest. 2020;130(7):3353–3360. doi:10.1172/JCI13622332484459
   PubMed Web of Science ®Google Scholar
• Ru L. 1861 cerebrospinal fluid test characteristics and clinical analysis (in Chinese). Pract J Clin Med. 2012;9(4):139–141.
   Google Scholar
• Kishor K, Dhasmana N, Kamble S, et al. Linezolid induced adverse drug reactions - An update. Curr Drug Metab. 2015;16(7):553–559. doi:10.2174/138920021666615100112100426424176
   PubMed Web of Science ®Google Scholar
• Swaminathan A, Du Cros P, Seddon JA, et al. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature. BMC Infect Dis. 2017;17(1):417. doi:10.1186/s12879-017-2499-128606115
   PubMed Web of Science ®Google Scholar
• Mehta S, M Das, C Laxmeshwar,et al. Linezolid-associated optic neuropathy in drug-resistant tuberculosis patients in Mumbai, India. PLoS One. 2016;11(9):e0162138. doi:10.1371/journal.pone.016213827611434
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu Y, Zhong Q, et al. Serious adverse reactions from anti-tuberculosis drugs among 599 children hospitalized for tuberculosis. Pediatr Infect Dis J. 2017;36(8):720–725. doi:10.1097/INF.000000000000153228060046
   PubMed Web of Science ®Google Scholar
• Kargar M, Mansouri A, Hadjibabaie M, et al. Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature. Expert Opin Drug Saf. 2014;13(7):875–891. doi:10.1517/14740338.2014.92544324935479
   PubMed Web of Science ®Google Scholar
• Liu EY, Chang J-C, Lin J-C, et al. Important mutations contributing to high-level penicillin resistance in Taiwan 19F-14, Taiwan 23F-15, and Spain 23F-1 of Streptococcus pneumoniae Isolated from Taiwan. Microb Drug Resist. 2016;22(8):646–654. doi:10.1089/mdr.2015.026127042760
   PubMed Web of Science ®Google Scholar
• Lu TL, Cao Y, Zhou L-X, et al. The antimicrobial resistance analysis of 73 strains of streptococcus pneumoniae isolated from infant respiratory tract. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015;46(3):417–421.26121865
   PubMedGoogle Scholar
• Klainer AS. Clindamycin. Med Clin North Am. 1987;71(6):1169–1175. doi:10.1016/S0025-7125(16)30804-53320618
   PubMed Web of Science ®Google Scholar
• Phillips I. Clinical uses and control of rifampicin and clindamycin. J Clin Pathol. 1971;24(5):410–418. doi:10.1136/jcp.24.5.4104999067
   PubMed Web of Science ®Google Scholar